NEW!

Human ApoCI

Bethyl Laboratories®
Bethyl Laboratories®

Catalog # P81-112

Target:

ApoCI

Conjugate:

Unconjugated

Purity:

Purified

0.5 mg

Product Details

Specifications
Concentration
1 mg/ml
Storage

Store at -20 °C

Shelf Life

1 year from date of receipt

Physical State
Liquid
Buffer

75 mM Sodium Phosphate, 75 m M NaCl, 1 mM EDTA, 0.02% NaN3, pH 7.4


Request Formulation Change

Fortis Guarantee

Guaranteed Performance, Excellent Service!
Additional Product Information

ApoCI contains 57 amino acid residues and the m.w. is 6.6 kDa (Jackson et al., 1974). ApoCI has been found to activate LCAT (Liu and Subbaiah 1993). Apo CI is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor. Apo CI is also an inhibitor of the plasma cholesteryl ester transfer protein and of fatty acid uptake into tissues (Shachter, 2001). This inhibition role can potentially regulate several lipase enzymes. (Poensgen, 1990, Conde-Knape et al., 2002; Berbee et al., 2005)

341

APOC1

apolipoprotein C1

P02654

Apolipoprotein C-I

Alternate Names

Apo-CI; ApoC-I; apo-CIB; apoC-IB; Apolipoprotein C1; apolipoprotein C-I